Connect your AI

Medline, Inc. MDLN Allowance for doubtful accounts

Allowance for doubtful accounts at other companies

Baxter InternationalBAX

——

Henry ScheinHSIC

——

SolventumSOLV

——

UFP TechnologiesUFPT

——

IAR

Integra LifeSciencesIART

——

Boston ScientificBSX

——

Other financials

Income statement

Revenue$7.4B+10.7%

Gross profit$1.8B+0.9%

Operating income$422.0M-26.1%

Net income$239.0M-25.1%

EPS (diluted)$0.16—

Balance sheet

Cash & equivalents$2.2B+166%

Total debt$12.6B—

Total equity$11.3B—

Total assets$39.0B—

Cash flow

Operating cash flow$412.0M-39.6%

CapEx$96.0M-2.0%

Free cash flow$316.0M-45.9%

Valuation

Market cap$33.35B+17.5%

Enterprise value$43.67B—

P/E39.6×—

P/S1.3×—

Profitability

Gross margin27.4%+1.5pp

Operating margin8.5%+2.3pp

Net margin4.6%+2.7pp

FCF margin6.4%+0.5pp

Returns & leverage

Return on equity7.7%—

Debt / equity1.1×—

Current ratio4.4×—

Where this comes from

Reported directly by Medline, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The official record: Medline, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medline, Inc. 's allowance for doubtful accounts.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Medline, Inc. 's allowance for doubtful accounts?: Medline, Inc. (MDLN) reported allowance for doubtful accounts of $148M in Q1 2026.